The p110β isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110γ

被引:279
作者
Guillermet-Guibert, Julie [1 ]
Bjorklof, Katja [1 ]
Salpekar, Ashreena [1 ]
Gonella, Cristiano [1 ]
Ramadani, Faruk [2 ]
Bilancio, Antonio [1 ]
Meek, Stephen [3 ]
Smith, Andrew J. H. [3 ]
Okkenhaug, Klaus [2 ]
Vanhaesebroeck, Bart [1 ]
机构
[1] Queen Mary Univ London, Inst Canc, Ctr Cell Signaling, London EC1M 6BQ, England
[2] Babraham Inst, Lab Lymphocyte Signaling & Dev, Cambridge CB2 3AT, England
[3] Univ Edinburgh, Gene Targeting Lab, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland
基金
英国医学研究理事会; 英国生物技术与生命科学研究理事会;
关键词
gene targeting; signaling; tyrosine kinase; Akt; insulin;
D O I
10.1073/pnas.0707761105
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The p110 isoforms of phosphoinositide,3-kinase (PI3K) are acutely regulated by extracellular stimuli. The class IA PI3K catalytic sub-units (p110 alpha, p110 beta, and p110 delta) occur in complex with a Src homology 2 (SH2) domain-containing p85 regulatory subunit, which has been shown to link p110 alpha and p110 delta to Tyr kinase signaling pathways. The p84/p101 regulatory subunits of the p110 gamma class IB PI3K lack SH2 domains and instead couple p110 gamma to G protein-coupled receptors (GPCRs). Here, we show, using small-molecule inhibitors with selectivity for p110 beta and cells derived from a p110 beta-deficient mouse line, that p110 beta is not a major effector of Tyr kinase signaling but couples to GPCRs. In macrophages, both p110 beta and p110 gamma contributed to Akt activation induced by the GPCR agonist complement 5a, but not by the Tyr kinase ligand colony-stimulating factor-1. In fibroblasts, which express p110 beta but not p110 gamma, p110 beta mediated Akt activation by the GPCR ligands stromal cell-derived factor, sphingosine-1-phosphate, and lysophosphatidic acid but not by the Tyr kinase ligands PDGF, insulin, and insulin-like growth factor 1. Introduction of p110 gamma in these cells reduced the contribution of p110 beta to GPCR signaling. Taken together, these data show that p110 beta and p110 gamma can couple redundantly to the same GPCR agonists. p110 beta, which shows a much broader tissue distribution than the leukocyterestricted p110 gamma, could thus provide a conduit for GPCR-linked PI3K signaling in the many cell types where p110 gamma expression is low or absent.
引用
收藏
页码:8292 / 8297
页数:6
相关论文
共 34 条
  • [1] Isoform-specific functions of phosphoinositide 3-kinases:: p110δ but not p110γ promotes optimal allergic responses in vivo
    Ali, Khaled
    Camps, Montserrat
    Pearce, Wayne P.
    Ji, Hong
    Rueckle, Thomas
    Kuehn, Nicolas
    Pasquali, Christian
    Chabert, Christian
    Rommel, Christian
    Vanhaesebroeck, Bart
    [J]. JOURNAL OF IMMUNOLOGY, 2008, 180 (04) : 2538 - 2544
  • [2] Early embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase
    Bi, L
    Okabe, I
    Bernard, DJ
    Nussbaum, RL
    [J]. MAMMALIAN GENOME, 2002, 13 (03) : 169 - 172
  • [3] Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice
    Brachmann, SM
    Ueki, K
    Engelman, JA
    Kahn, RC
    Cantley, LC
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (05) : 1596 - 1607
  • [4] Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis
    Camps, M
    Rückle, T
    Ji, H
    Ardissone, V
    Rintelen, F
    Shaw, J
    Ferrandi, C
    Chabert, C
    Gillieron, C
    Françon, B
    Martin, T
    Gretener, D
    Perrin, D
    Leroy, D
    Vitte, PA
    Hirsch, E
    Wymann, MP
    Cirillo, R
    Schwarz, MK
    Rommel, C
    [J]. NATURE MEDICINE, 2005, 11 (09) : 936 - 943
  • [5] Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling
    Chaussade, Claire
    Rewcastle, Gordon W.
    Kendall, Jackie D.
    Denny, William A.
    Cho, Kitty
    Gronning, Line M.
    Chong, Mel Ling
    Anagnostou, Sasha H.
    Jackson, Shaun P.
    Daniele, Nathalie
    Shepherd, Peter R.
    [J]. BIOCHEMICAL JOURNAL, 2007, 404 : 449 - 458
  • [6] Phosphatidylinositol-3-OH kinases are Rab5 effectors
    Christoforidis, S
    Miaczynska, M
    Ashman, K
    Wilm, M
    Zhao, LY
    Yip, SC
    Waterfield, MD
    Backer, JM
    Zerial, M
    [J]. NATURE CELL BIOLOGY, 1999, 1 (04) : 249 - 252
  • [7] Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation
    Foukas, LC
    Claret, M
    Pearce, W
    Okkenhaug, K
    Meek, S
    Peskett, E
    Sancho, S
    Smith, AJH
    Withers, DJ
    Vanhaesebroeck, B
    [J]. NATURE, 2006, 441 (7091) : 366 - 370
  • [8] Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers
    Geering, Barbara
    Cutillas, Pedro R.
    Nock, Gemma
    Gharbi, Severine I.
    Vanhaesebroeck, Bart
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (19) : 7809 - 7814
  • [9] A novel mitogenic signaling pathway of bradykinin in the human colon carcinoma cell line SW-480 involves sequential activation of a Gq/11 protein, phosphatidylinositol 3-kinase β, and protein kinase C∈
    Graness, A
    Adomeit, A
    Heinze, R
    Wetzker, R
    Liebmann, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) : 32016 - 32022
  • [10] Specific requirement for the p85-p110α phosphatidylinositol 3-kinase during epidermal growth factor-stimulated actin nucleation in breast cancer cells
    Hill, K
    Welti, S
    Yu, JH
    Murray, JT
    Yip, SC
    Condeelis, JS
    Segall, JE
    Backer, JM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (06) : 3741 - 3744